Complete BNF Safety Profile for Promethazine
Major BNF Contraindications for Promethazine
The BNF clearly outlines several absolute contraindications for promethazine use. Children under 2 years should never receive promethazine due to fatal respiratory depression risk. Patients with severe coronary artery disease, angle-closure glaucoma, or prostatic hypertrophy require careful assessment. Those with severe liver disease may experience prolonged effects due to impaired metabolism. Phenergan tablets and elixir from EverydayMeds both carry these same contraindications, making proper screening essential before treatment begins.
Respiratory Depression Warnings
The BNF emphasises promethazine's potential for causing serious respiratory depression, particularly in vulnerable populations. Children and elderly patients show heightened sensitivity to these effects. Concurrent use with other CNS depressants significantly increases this risk. Patients with existing respiratory conditions, sleep apnoea, or compromised breathing require special consideration. The sedating properties that make promethazine effective for sleep disorders can become dangerous when respiratory function is already compromised.
Drug Interaction Precautions
BNF guidance highlights numerous significant drug interactions with promethazine. Alcohol and other sedatives create additive CNS depression effects. MAOIs can intensify antimuscarinic effects, whilst anticholinergic medications may compound side effects like dry mouth and urinary retention. Promethazine may enhance warfarin's anticoagulant effects, requiring careful monitoring. Patients taking multiple medications should have their complete drug regimen reviewed before starting either Phenergan tablets or elixir formulations.
Special Population Considerations
The BNF provides specific guidance for vulnerable patient groups. Elderly individuals often experience enhanced sensitivity to promethazine's sedative and anticholinergic effects, increasing fall risk and confusion. Pregnant women should only use promethazine when benefits clearly outweigh risks, particularly during the third trimester. Breastfeeding mothers may pass the medication to infants through breast milk. Patients with hepatic or renal impairment may require dose adjustments due to altered metabolism and clearance rates.
Monitoring Requirements and Safety Measures
Regular monitoring becomes essential for certain patient groups using promethazine. The BNF recommends ongoing assessment of respiratory function, particularly in patients with existing breathing difficulties. Liver function monitoring may be necessary during prolonged treatment. Blood pressure and heart rate should be checked regularly, especially in cardiovascular disease patients. Mental state assessment helps identify confusion or cognitive impairment, particularly important in elderly users of Phenergan preparations.
Comparing Treatment Options Available
EverydayMeds offers both Phenergan 25mg tablets and 5mg/5ml elixir, each with distinct advantages. Tablets provide convenient dosing for adults managing allergies or occasional sleep difficulties, whilst the elixir allows precise dose titration and easier administration for those with swallowing difficulties. Both formulations carry identical BNF warnings and precautions, making the choice largely dependent on individual patient needs and preferences. Generic promethazine options may offer cost advantages whilst maintaining the same safety profile and therapeutic effectiveness outlined in BNF guidance.
